# FDA Inspection 983376 - Octapharma Plasma, Inc. - August 04, 2016

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/1363075c-5b9b-4337-9e64-24dcf52c4085
Source feed: FDA_Inspections

> FDA Inspection 983376 for Octapharma Plasma, Inc. on August 04, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 983376
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2016-08-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1305404 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/ad4376c9-43b6-4453-a09a-944b4a733ca0)
- [FDA Inspection 1305404 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/cde5effc-016e-40e9-8b92-a2e1d8b44b90)
- [FDA Inspection 1106295 - 2019-09-12](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5f5cc09f-e649-4af1-b127-73b25543af05)
- [FDA Inspection 868647 - 2014-02-27](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/8d43f0c0-0f1a-420f-95d7-880d7106304b)
- [FDA Inspection 779650 - 2012-04-09](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/94941d6f-9305-4563-a57b-5278b0723762)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/3f529220-65f3-43dd-98b4-3483490adf93

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d